Search

everythinglearnresearchcommunity

for

Search:↓

Reproductive factors can increase hypertension risk and affect cardiovascular health.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

The apelinergic system might protect the heart from damage caused by doxorubicin.

No effective treatment for hair loss after childbirth was found, but it usually gets better on its own and some cosmetic methods might help.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Low testosterone may increase COVID-19 severity in men.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

COVID-19 can harm many body parts, not just the lungs.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

COVID-19 can cause or worsen skin issues.

Hair loss doesn't affect COVID-19 severity.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

Many hair diseases, including those caused by medications and psychological issues, can lead to hair loss and require proper treatment and specialist care.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Indian men have 62.1% hair loss, mostly grade II vertex, and less extensive than other populations.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

ADAM17 could be a potential target for treating PCOS.